Arcadia Biosciences (RKDA) Revenue & Revenue Breakdown
Arcadia Biosciences Revenue Highlights
Latest Revenue (Y)
$5.33M
Latest Revenue (Q)
$1.25M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
Arcadia Biosciences Revenue by Period
Arcadia Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.33M | -46.46% |
| 2022-12-31 | $9.96M | 46.84% |
| 2021-12-31 | $6.78M | -15.61% |
| 2020-12-31 | $8.03M | 587.25% |
| 2019-12-31 | $1.17M | -20.15% |
| 2018-12-31 | $1.46M | -63.64% |
| 2017-12-31 | $4.03M | 26.29% |
| 2016-12-31 | $3.19M | -41.12% |
| 2015-12-31 | $5.41M | -22.46% |
| 2014-12-31 | $6.98M | 7.78% |
| 2013-12-31 | $6.48M | -7.59% |
| 2012-12-31 | $7.01M | - |
Arcadia Biosciences generated $5.33M in revenue during NA 2023, up -46.46% compared to the previous quarter, and up 364.07% compared to the same period a year ago.
Arcadia Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.25M | 7.26% |
| 2023-12-31 | $1.17M | -26.74% |
| 2023-09-30 | $1.60M | 14.97% |
| 2023-06-30 | $1.39M | -7.95% |
| 2023-03-31 | $1.51M | 50.90% |
| 2022-12-31 | $1.00M | -46.75% |
| 2022-09-30 | $1.88M | -51.32% |
| 2022-06-30 | $3.86M | 19.81% |
| 2022-03-31 | $3.22M | 48.32% |
| 2021-12-31 | $2.17M | -8.63% |
| 2021-09-30 | $2.38M | 69.11% |
| 2021-06-30 | $1.41M | 69.69% |
| 2021-03-31 | $828.00K | -88.39% |
| 2020-12-31 | $7.13M | 2170.70% |
| 2020-09-30 | $314.00K | 11.74% |
| 2020-06-30 | $281.00K | -9.06% |
| 2020-03-31 | $309.00K | -25.72% |
| 2019-12-31 | $416.00K | 6.12% |
| 2019-09-30 | $392.00K | 93.10% |
| 2019-06-30 | $203.00K | 28.48% |
| 2019-03-31 | $158.00K | -64.41% |
| 2018-12-31 | $444.00K | 20.00% |
| 2018-09-30 | $370.00K | -15.14% |
| 2018-06-30 | $436.00K | 103.74% |
| 2018-03-31 | $214.00K | -85.01% |
| 2017-12-31 | $1.43M | 142.44% |
| 2017-09-30 | $589.00K | -40.57% |
| 2017-06-30 | $991.00K | -2.65% |
| 2017-03-31 | $1.02M | 88.52% |
| 2016-12-31 | $540.00K | -49.77% |
| 2016-09-30 | $1.07M | 49.10% |
| 2016-06-30 | $721.00K | -15.38% |
| 2016-03-31 | $852.00K | -36.70% |
| 2015-12-31 | $1.35M | -26.17% |
| 2015-09-30 | $1.82M | 27.48% |
| 2015-06-30 | $1.43M | 75.46% |
| 2015-03-31 | $815.00K | -70.87% |
| 2014-12-31 | $2.80M | 86.28% |
| 2014-09-30 | $1.50M | 15.10% |
| 2014-06-30 | $1.30M | -5.23% |
| 2014-03-31 | $1.38M | -31.22% |
| 2013-12-31 | $2.00M | 10.00% |
| 2013-09-30 | $1.82M | - |
Arcadia Biosciences generated $1.25M in revenue during Q1 2024, up 7.26% compared to the previous quarter, and up 125.50% compared to the same period a year ago.
Arcadia Biosciences Revenue Breakdown
Arcadia Biosciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Royalty | $117.00K | $176.00K | $83.00K | - | - |
| License | $879.00K | $17.00K | $6.80M | $67.00K | $150.00K |
| Product | $8.96M | $6.59M | $1.04M | $814.00K | $657.00K |
| Contract Research And Government Grants | - | - | $106.00K | $288.00K | $657.00K |
Arcadia Biosciences's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (90.00%), License (8.83%), and Royalty (1.18%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License | - | $10.00K | $7.00K | $10.00K | $862.00K | - | $17.00K | $6.69M | $10.00K | - | $100.00K | $50.00K | $17.00K | - | - | - | - | - | - | - |
| Product | $1.31M | $1.25M | $1.38M | $1.51M | $993.00K | $1.85M | $2.95M | $3.17M | $2.08M | $2.32M | $1.38M | $803.00K | $414.00K | $245.00K | $231.00K | $154.00K | $329.00K | $216.00K | $162.00K | $107.00K |
| Royalty | - | - | - | - | - | $17.00K | $50.00K | $50.00K | $90.00K | $35.00K | $26.00K | $25.00K | $25.00K | $16.00K | $12.00K | $30.00K | - | - | - | - |
| Contract Research And Government Grants | - | - | - | - | - | - | - | - | - | - | - | - | - | $43.00K | $38.00K | $25.00K | $37.00K | $159.00K | $41.00K | $51.00K |
Arcadia Biosciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (100.00%).
Arcadia Biosciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| ARGENTINA | $862.00K | $26.00K | $6.68M | - | - |
| UNITED STATES | $8.84M | $6.00M | $761.00K | $722.00K | $1.17M |
| INDIA | $7.00K | $7.00K | $100.00K | $7.00K | $90.00K |
| GERMANY | $57.00K | - | - | - | - |
| CANADA | $194.00K | $503.00K | $354.00K | $258.00K | $91.00K |
| SPAIN | - | $225.00K | - | - | - |
| Africa | - | - | $106.00K | $182.00K | $115.00K |
| AUSTRIA | - | - | $32.00K | - | - |
Arcadia Biosciences's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (88.75%), ARGENTINA (8.66%), CANADA (1.95%), GERMANY (0.57%), and INDIA (0.07%).
Arcadia Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SENEA | Seneca Foods | $1.46B | $304.73M |
| BRID | Bridgford Foods | $251.64M | $49.26M |
| FAMI | Farmmi | $110.36M | $49.82M |
| RIBT | RiceBran | $41.62M | $2.12M |
| YGF | YanGuFang Group | $36.08M | - |
| SMFL | Smart for Life | $17.77M | $2.75M |
| SNAX | Stryve Foods | $17.71M | $6.18B |
| BTOG | Bit Origin | $6.26M | $2.89M |
| RKDA | Arcadia Biosciences | $5.33M | $1.25M |
RKDA Revenue FAQ
What is Arcadia Biosciences’s yearly revenue?
Arcadia Biosciences's yearly revenue for 2023 was $5.33M, representing a decrease of -46.46% compared to 2022. The company's yearly revenue for 2022 was $9.96M, representing an increase of 46.84% compared to 2021. RKDA's yearly revenue for 2021 was $6.78M, representing a decrease of -15.61% compared to 2020.
What is Arcadia Biosciences’s quarterly revenue?
Arcadia Biosciences's quarterly revenue for Q1 2024 was $1.26M, a 7.26% increase from the previous quarter (Q4 2023), and a -16.83% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.17M, a -26.74% decrease from the previous quarter (Q3 2023), and a 17.00% increase year-over-year (Q4 2022). RKDA's quarterly revenue for Q3 2023 was $1.6M, a 14.97% increase from the previous quarter (Q2 2023), and a -14.96% decrease year-over-year (Q3 2022).
What is Arcadia Biosciences’s revenue growth rate?
Arcadia Biosciences's revenue growth rate for the last 3 years (2021-2023) was -21.39%, and for the last 5 years (2019-2023) was 355.95%.
What are Arcadia Biosciences’s revenue streams?
Arcadia Biosciences's revenue streams in c 22 are Royalty, License, and Product. Royalty generated $117K in revenue, accounting 1.18% of the company's total revenue, down -33.52% year-over-year. License generated $879K in revenue, accounting 8.83% of the company's total revenue, up 5070.59% year-over-year. Product generated $8.96M in revenue, accounting 90.00% of the company's total revenue, up 36.03% year-over-year.
What is Arcadia Biosciences’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Arcadia Biosciences was Product. This segment made a revenue of $8.96M, representing 90.00% of the company's total revenue.